Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stone, M. D.
Right arrow Articles by Williams, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stone, M. D.
Right arrow Articles by Williams, B. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2003, Vol. 91, No. 5 619-624
© 2003 The Board of Management and Trustees of the British Journal of Anaesthesia

Clinical Investigations

Effect of adding dopexamine to intraoperative volume expansion in patients undergoing major elective abdominal surgery{dagger}

M. D. Stone, R. J. T. Wilson*, J. Cross and B. T. Williams

Department of Anaesthesia, York District Hospital, Wigginton Road, York YO31 8HE, UK

Corresponding author. E-mail: rjtwilson@doctors.org.uk
{dagger}This article is accompanied by the Editorial.

Background. The contribution of low-dose dopexamine to outcome, when given to increase cardiac output in patients already treated with fluids during major abdominal surgery, is not yet known.

Method. We carried out a randomized double-blind placebo-controlled trial. All 100 patients studied were given fluid infusions during surgery guided by stroke volume measurements made with an oesophageal Doppler probe. Patients were randomized to receive dopexamine at the rate of 0.25 µg kg–1 min–1 or saline 0.9% (control) for the first 24 h after the start of surgery. The primary outcome measure was the incidence of postoperative morbidity.

Results. There were no statistically significant differences between groups in the incidence of postoperative complications, the length of hospital stay, the incidence of morbidity and the use of critical care facilities. The patients randomized to receive dopexamine had significantly more pre-existing disease than the control patients. Mortality in both groups was significantly less than predicted by the POSSUM (Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity) risk prediction score.

Conclusion. We could not demonstrate an advantage to using low-dose dopexamine in high-risk patients during major abdominal surgery.

Br J Anaesth 2003; 91: 619–24


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
P. J. M. Bayly and R. J. T. Wilson
Effect of adding dopexamine to intraoperative volume expansion in patients undergoing major elective abdominal surgery
Br. J. Anaesth., April 1, 2004; 92(4): 598 - 599.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
S. J. Mackenzie
Should perioperative management target oxygen delivery?
Br. J. Anaesth., November 1, 2003; 91(5): 615 - 618.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.